Return to content in this issue

Successful Desensitization to Lenalidomide in Leukocytoclastic Vasculitis

Fernández-Concha I¹, Pose K¹, de las Vecillas L^1,2, Lluch-Bernal M^1,2, Tomás-Pérez M^1,2, Soto T^2,3, López de la Guía A^2,3, Cabañas R<sup>1,2,4,5

1</sup>Allergy Department, Hospital Universitario La Paz, Madrid, Spain
²Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
³Hematology Department, Hospital Universitario La Paz, Madrid, Spain
⁴PIELenRed consortium
⁵Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain

J Investig Allergol Clin Immunol 2024; Vol 34(5) : 352-353
doi: 10.18176/jiaci.1002

• Abstract
• Supplemental Materials

Key words: Leukocytoclastic vasculitis, Desensitization protocol, Lenalidomide, Multiple myeloma

	Title	Type	Size
	doi10.18176_jiaci.1002_supplemental-materials-figure_2.pdf	pdf	306.35 Kb